BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26168233)

  • 1. CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis.
    Hutchenreuther J; Vincent KM; Carter DE; Postovit LM; Leask A
    J Invest Dermatol; 2015 Nov; 135(11):2805-2813. PubMed ID: 26168233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma.
    Hutchenreuther J; Vincent K; Norley C; Racanelli M; Gruber SB; Johnson TM; Fullen DR; Raskin L; Perbal B; Holdsworth DW; Postovit LM; Leask A
    Matrix Biol; 2018 Dec; 74():52-61. PubMed ID: 29885461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory microenvironment and tumor necrosis factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds and dermal fibroblasts.
    Elliott CG; Forbes TL; Leask A; Hamilton DW
    Matrix Biol; 2015 Apr; 43():71-84. PubMed ID: 25779637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.
    Xiu M; Liu YH; Brigstock DR; He FH; Zhang RJ; Gao RP
    World J Gastroenterol; 2012 Dec; 18(47):7070-8. PubMed ID: 23323010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Kim CJ; Yoshioka N; Tambe Y; Kushima R; Okada Y; Inoue H
    Int J Cancer; 2005 Oct; 117(1):51-8. PubMed ID: 15880581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN2 expression by fibroblasts is not required for cutaneous tissue repair.
    Liu S; Thompson K; Leask A
    Wound Repair Regen; 2014; 22(1):119-24. PubMed ID: 24393160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN2 is required for bleomycin-induced skin fibrosis in mice.
    Liu S; Shi-wen X; Abraham DJ; Leask A
    Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN2 expression and localization in melanoma cells.
    Sha W; Leask A
    J Cell Commun Signal; 2011 Aug; 5(3):219-26. PubMed ID: 21667293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Fibroblast Plasticity: Cellular Communication Network 2 Is Required for Activation of Cancer-Associated Fibroblasts in a Murine Model of Melanoma.
    Tsang M; Quesnel K; Vincent K; Hutchenreuther J; Postovit LM; Leask A
    Am J Pathol; 2020 Jan; 190(1):206-221. PubMed ID: 31610176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2.
    Liu S; Parapuram SK; Leask A
    Arthritis Rheum; 2013 Nov; 65(11):2940-4. PubMed ID: 23983074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism.
    Parapuram SK; Thompson K; Tsang M; Hutchenreuther J; Bekking C; Liu S; Leask A
    Matrix Biol; 2015 Apr; 43():35-41. PubMed ID: 25644104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma: impact on keratinocyte proliferation and stromal cell activation.
    Quan T; Xu Y; Qin Z; Robichaud P; Betcher S; Calderone K; He T; Johnson TM; Voorhees JJ; Fisher GJ
    Am J Pathol; 2014 Apr; 184(4):937-943. PubMed ID: 24485923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Barrasa E; Rico-Leo EM; Catalina-Fernández I; Menacho-Márquez M; Bustelo XR; García-Borrón JC; Gómez-Durán A; Sáenz-Santamaría J; Fernández-Salguero PM
    Carcinogenesis; 2013 Dec; 34(12):2683-93. PubMed ID: 23843039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo.
    Li L; Dragulev B; Zigrino P; Mauch C; Fox JW
    Int J Cancer; 2009 Oct; 125(8):1796-804. PubMed ID: 19569239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.
    Prada F; Benedetti LG; Bravo AI; Alvarez MJ; Carbone C; Podhajcer OL
    J Invest Dermatol; 2007 Nov; 127(11):2618-28. PubMed ID: 17625595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
    Fukuda K; Sugihara E; Ohta S; Izuhara K; Funakoshi T; Amagai M; Saya H
    PLoS One; 2015; 10(6):e0129704. PubMed ID: 26083413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression.
    Xander P; Brito RR; Pérez EC; Pozzibon JM; de Souza CF; Pellegrino R; Bernardo V; Jasiulionis MG; Mariano M; Lopes JD
    Immunobiology; 2013 Oct; 218(10):1293-303. PubMed ID: 23731774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
    Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
    Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenchyma-stromal interactions induce fibrosis by secreting CCN2 and promote osteoclastogenesis by stimulating RANKL and CD68 through activated TGF-β/BMP4 in ameloblastoma.
    Takebe Y; Tsujigiwa H; Katase N; Siar CH; Takabatake K; Fujii M; Tamamura R; Nakano K; Nagatsuka H
    J Oral Pathol Med; 2017 Jan; 46(1):67-75. PubMed ID: 27327904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.